BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on systemic and inhaled fluoroquinolones: risk of aortic aneurysm and dissection

Active substance: fluoroquinolones

The marketing authorisation holders of fluoroquinolone-containing medicinal products would like to inform about a new warning regarding the risk of aortic aneurysm and dissection associated with the use of systemic or inhaled fluoroquinolones.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 2MB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK